Zhongchao Inc (ZCMD) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments PR Newswire SHANGHAI, Dec. 11...

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day PR...

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients PR Newswire SHANGHAI, Sept. 25, 2023 SHANGHAI, Sept. 25...

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management PR Newswire SHANGHAI, Aug. 24, 2023...

Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education

Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education PR Newswire SHANGHAI, July 11, 2023 SHANGHAI...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment

Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment PR Newswire SHANGHAI, June 12, 2023...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF...

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya PR Newswire SHANGHAI, May 12, 2023 SHANGHAI, May 12, 2023 /PRNewswire/ -- Zhongchao...

Annual and Transition Report (foreign Private Issuer) (20-f)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 20-F   ...

Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China

Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China PR...

Notification That Form 20-f Will Be Submitted Late (nt 20-f)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health

Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health PR Newswire SHANGHAI, April 24, 2023 SHANGHAI, April...

Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform

Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform PR Newswire SHANGHAI, March 30, 2023 SHANGHAI, March...